Promoting research partnerships to improve veterans’ health

NAVREF Updates for the week of July 20th

22 Jul 2020 9:36 AM | Anonymous member (Administrator)
  1. The 28th NAVREF Annual Conference is open for registration at  This year’s virtual event will run from 12-4pm ET on September 14-16th with 5 plenary sessions, 12 breakout sessions, several “On Demand” sessions, and a variety of networking opportunities with colleagues and sponsors.  Register now for up to 3 individuals ($200) or up to 8 individuals ($400) from your site.  In addition to CEO/EDs and senior staff, NPCs should include ACOS-Rs and consider other research service staff as attendees within your group.  Please contact Hawk with any questions,   
  1. Reminder:  NAVREF annual membership renewal/enrollment ran from June 1-30.  Thank you to all of you who renewed for 2020-2021.  We are ahead of last year’s pace with only 10 NPCs remaining—to those of you who have not yet contacted us, please complete and return the 2020-2021 membership renewal packet with your most recent IRS form 990.  Due to the pandemic, NAVREF is offering flexible payment arrangements for anyone in need.
  1. ORD COVID-19 Update – attached is the most current weekly update from ORD.  Most relevant for NPCs are pages 5-6 under “New Research Opportunities” related to Vaccine and therapeutic trials and the ACTIV site survey. 
  1. Upcoming training sessions:               Thu, Jul 23, 1pm ET; Incorporating Grants and Grant Strategy into your Organization
  1. PPP Forgiveness:  see attached message from Non Profit Quarterly offering a complimentary webinar for nonprofit financial leaders who have received a Paycheck Protection Program (PPP) loan and want to prepare effectively to seek loan forgiveness.  The webinar will be presented live on Thursday, July 23rd 2020 from 3:00 - 4:00PM ET and the recording will be made available 2-3 days after.
  1. As NAVREF members, you each have full membership with the Society for Clinical Research Sites (SCRS).  Please see attached message highlighting how to take advantage of your valuable SCRS benefits.
  1. Working Together in the Public Interest: Over 20 of the largest global pharmaceutical companies, joined by WHO and other multilateral organizations, have created a billion-dollar fund to support antibiotic R&D by smaller companies. The AMR Action Fund aims to reverse the dangerously fragile antibiotic pipeline. For background on AMR, go to
  1. Check out the attached chart from the Adult Vaccine Access Coalition (AVAC) showing how the current vaccine development process is accelerating vaccine development to prevent COVID-19.

1717 K ST NW Suite 900

Washington, DC 20006

202-951-7701  |

FEIN: 52-1784596

Powered by Wild Apricot Membership Software